Bridgeway Capital Management’s Aevi Genomic Medicine Inc GNMX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-223,500	Closed	-$44K	–	1431
2019 Q1	$44K	Hold	223,500	–	–	﹤0.01%	1316
2018 Q4	$156K	Hold	223,500	–	–	﹤0.01%	1252
2018 Q3	$275K	Buy	+223,500	New	+$250K	﹤0.01%	1267
2017 Q2	–	Sell	-187,500	Closed	-$349K	–	1498
2017 Q1	$349K	Hold	187,500	–	–	﹤0.01%	1171
2016 Q4	$971K	Hold	187,500	–	–	0.01%	833
2016 Q3	$1.04M	Buy	187,500 +30,000	+19%	+$171K	0.02%	776
2016 Q2	$874K	Buy	157,500 +38,500	+32%	+$202K	0.01%	829
2016 Q1	$524K	Hold	119,000	–	–	0.01%	1027
2015 Q4	$716K	Hold	119,000	–	–	0.01%	908
2015 Q3	$931K	Hold	119,000	–	–	0.02%	774
2015 Q2	$729K	Buy	119,000 +40,000	+51%	+$310K	0.01%	906
2015 Q1	$636K	Buy	79,000 +8,614	+12%	+$65K	0.01%	988
2014 Q4	$356K	Sell	70,386 -9,614	-12%	-$47.5K	0.01%	1176
2014 Q3	$415K	Hold	80,000	–	–	0.01%	1168
2014 Q2	$622K	Hold	80,000	–	–	0.02%	985
2014 Q1	$558K	Buy	80,000 +40,000	+100%	+$312K	0.02%	1022
2013 Q4	$240K	Sell	40,000 -29,400	-42%	-$192K	0.01%	1263
2013 Q3	$541K	Buy	69,400 +15,000	+28%	+$69.6K	0.02%	997
2013 Q2	$207K	Buy	+54,400	New	+$223K	0.01%	1264